These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 2884839
1. Different patterns of disease in two inbred mouse strains infected with a clone of Leishmania mexicana amazonensis. Barral-Netto M, Cardoso SA, Barral A. Acta Trop; 1987 Mar; 44(1):5-11. PubMed ID: 2884839 [Abstract] [Full Text] [Related]
2. Immune serum from both susceptible and resistant strains of mice increases phagocytosis of Leishmania mexicana amazonensis by macrophages. Reis MG, Roters SB, Barral-Netto M. Acta Trop; 1987 Sep; 44(3):339-42. PubMed ID: 2892370 [Abstract] [Full Text] [Related]
3. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice. Rosas LE, Keiser T, Barbi J, Satoskar AA, Septer A, Kaczmarek J, Lezama-Davila CM, Satoskar AR. Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242 [Abstract] [Full Text] [Related]
4. Leishmania amazonensis: humoral response to amastigote excreted-antigens in murine leishmaniasis. Hernández-Chinea C. Exp Parasitol; 2007 Aug; 116(4):492-6. PubMed ID: 17349625 [Abstract] [Full Text] [Related]
5. Histopathologic changes induced by vaccination in experimental cutaneous leishmaniasis of BALB/c mice. Barral-Netto M, de Freitas LA, Andrade ZA. Am J Pathol; 1987 May; 127(2):271-8. PubMed ID: 3495185 [Abstract] [Full Text] [Related]
6. Infection of BALB/c, C57B1/6 mice and F1 hybrid CB6F1 mice with strains of Leishmania mexicana isolated from Mexican patients with localized or diffuse cutaneous leishmaniasis. Monroy-Ostria A, Fuentes-Fraga I, García-Flores C, Favila-Castillo L. Arch Med Res; 1994 May; 25(4):401-6. PubMed ID: 7858398 [Abstract] [Full Text] [Related]
7. Leishsmania (Leishmania) amazonensis infection: Muscular involvement in BALB/c and C3H.HeN mice. Silva-Almeida M, Carvalho LO, Abreu-Silva AL, d'Escoffier LN, Calabrese KS. Exp Parasitol; 2010 Mar; 124(3):315-8. PubMed ID: 19944691 [Abstract] [Full Text] [Related]
8. Factors influencing the host response to Leishmania mexicana. Pérez H. Ciba Found Symp; 1983 Mar; 99():157-73. PubMed ID: 6227462 [Abstract] [Full Text] [Related]
9. T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana. Torrentera FA, Glaichenhaus N, Laman JD, Carlier Y. Infect Immun; 2001 Jan; 69(1):617-21. PubMed ID: 11119565 [Abstract] [Full Text] [Related]
10. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro. Sadick MD, Locksley RM, Tubbs C, Raff HV. J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789 [Abstract] [Full Text] [Related]
11. [Independence of the delayed hypersensitivity response from protection against Leishmania mexicana pifanoi]. Pérez HA, De la Rora M. Acta Cient Venez; 1986 Jan; 37(5):542-6. PubMed ID: 2966535 [No Abstract] [Full Text] [Related]
12. Adjuvant effect of Taenia crassiceps glycans against leishmanial antigens in mice infected with Leishmania mexicana. Dissanayake S, Shahin A, Ameen AM. Mol Immunol; 2005 Aug; 42(12):1495-502. PubMed ID: 15950742 [Abstract] [Full Text] [Related]
13. Leishmania (Leishmania) amazonensis infection and dissemination in mice inoculated with stationary-phase or with purified metacyclic promastigotes. Felizardo TC, Toma LS, Borges NB, Lima GM, Abrahamsohn IA. Parasitology; 2007 Nov; 134(Pt 12):1699-707. PubMed ID: 17655808 [Abstract] [Full Text] [Related]
14. The effects of protein malnutrition on the course of Leishmania mexicana infection in C57Bl/6 mice: nutrition and susceptibility to leishmaniasis. Pérez H, Malavé I, Arredondo B. Clin Exp Immunol; 1979 Dec; 38(3):453-60. PubMed ID: 535184 [Abstract] [Full Text] [Related]
15. Early infection with Leishmania major restrains pathogenic response to Leishmania amazonensis and parasite growth. González-Lombana CZ, Santiago HC, Macedo JP, Seixas VA, Russo RC, Tafuri WL, Afonso LC, Vieira LQ. Acta Trop; 2008 Apr; 106(1):27-38. PubMed ID: 18313021 [Abstract] [Full Text] [Related]
16. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40. Hernández MX, Barçante TA, Vilela L, Tafuri WL, Afonso LC, Vieira LQ. Immunol Lett; 2006 May 15; 105(1):38-47. PubMed ID: 16466810 [Abstract] [Full Text] [Related]
17. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity. Titus RG, Lima GC, Engers HD, Louis JA. J Immunol; 1984 Sep 15; 133(3):1594-600. PubMed ID: 6205088 [Abstract] [Full Text] [Related]
18. Resistance to macrophage-mediated killing as a factor influencing the pathogenesis of chronic cutaneous leishmaniasis. Scott P, Sacks D, Sher A. J Immunol; 1983 Aug 15; 131(2):966-71. PubMed ID: 6863939 [Abstract] [Full Text] [Related]
20. Influence of long-term treatment with pravastatin on the survival, evolution of cutaneous lesion and weight of animals infected by Leishmania amazonensis. Kückelhaus CS, Kückelhaus SA, Muniz-Junqueira MI. Exp Parasitol; 2011 Mar 15; 127(3):658-64. PubMed ID: 21176775 [Abstract] [Full Text] [Related] Page: [Next] [New Search]